Genetic variants in anti-mullerian hormone and anti-mullerian hormone receptor genes and breast cancer risk in caucasians and African Americans

Hongmei Nan, Joanne F. Dorgan, Timothy R. Rebbeck

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Anti-Mullerian hormone (AMH) regulates ovarian folliculogenesis by signaling via its receptors, and elevat­ed serum AMH levels are associated with an increased risk of breast cancer. No previous studies have examined the effects of genetic variants in AMH-related genes on breast cancer risk. We evaluated the associations of 62 single nucleotide polymorphisms (SNPs) in AMH and its receptor genes, including AMH type 1 receptor (ACVR1) and AMH type 2 receptor (AMHR2), with the risk of breast cancer in the Women’s Insights and Shared Experiences (WISE) Study of Caucasians (346 cases and 442 controls), as well as African Americans (149 cases and 246 controls). Of the 62 SNPs evaluated, two showed a nominal significant association (P for trend < 0.05) with breast cancer risk among Caucasians, and another two among African Americans. The age-adjusted additive odds ratios (ORs) (95% confidence interval (95% CI)) of those two SNPs (ACVR1 rs12694937[C] and ACVR1 rs2883605[T]) for the risk of breast cancer among Caucasian women were 2.33 (1.20-4.52) and 0.68 (0.47-0.98), respectively. The age-adjusted additive ORs (95% CI) of those two SNPs (ACVR1 rs1146031[G] and AMHR2 functional SNP rs2002555[G]) for the risk of breast cancer among African American women were 0.63 (0.44-0.92) and 1.67 (1.10-2.53), respectively. However, these SNPs did not show significant associations after correction for multiple testing. Our findings do not provide strong supportive evidence for the contribution of genetic variants in AMH-related genes to the risk of developing breast cancer in either Caucasians or African Americans.

Original languageEnglish (US)
Pages (from-to)145-151
Number of pages7
JournalInternational Journal of Molecular Epidemiology and Genetics
Volume5
Issue number3
StatePublished - Jan 1 2014

Fingerprint

Anti-Mullerian Hormone
African Americans
Single Nucleotide Polymorphism
Breast Neoplasms
Genes
Odds Ratio
Confidence Intervals
anti-Mullerian hormone receptor
Serum

Keywords

  • Anti-Mullerian hormone
  • Anti-Mullerian hormone receptors
  • Breast cancer
  • Single nucleotide polymorphism

ASJC Scopus subject areas

  • Epidemiology
  • Genetics
  • Genetics(clinical)

Cite this

@article{afc2a97321e44703979b9d437acf045e,
title = "Genetic variants in anti-mullerian hormone and anti-mullerian hormone receptor genes and breast cancer risk in caucasians and African Americans",
abstract = "Anti-Mullerian hormone (AMH) regulates ovarian folliculogenesis by signaling via its receptors, and elevat­ed serum AMH levels are associated with an increased risk of breast cancer. No previous studies have examined the effects of genetic variants in AMH-related genes on breast cancer risk. We evaluated the associations of 62 single nucleotide polymorphisms (SNPs) in AMH and its receptor genes, including AMH type 1 receptor (ACVR1) and AMH type 2 receptor (AMHR2), with the risk of breast cancer in the Women’s Insights and Shared Experiences (WISE) Study of Caucasians (346 cases and 442 controls), as well as African Americans (149 cases and 246 controls). Of the 62 SNPs evaluated, two showed a nominal significant association (P for trend < 0.05) with breast cancer risk among Caucasians, and another two among African Americans. The age-adjusted additive odds ratios (ORs) (95{\%} confidence interval (95{\%} CI)) of those two SNPs (ACVR1 rs12694937[C] and ACVR1 rs2883605[T]) for the risk of breast cancer among Caucasian women were 2.33 (1.20-4.52) and 0.68 (0.47-0.98), respectively. The age-adjusted additive ORs (95{\%} CI) of those two SNPs (ACVR1 rs1146031[G] and AMHR2 functional SNP rs2002555[G]) for the risk of breast cancer among African American women were 0.63 (0.44-0.92) and 1.67 (1.10-2.53), respectively. However, these SNPs did not show significant associations after correction for multiple testing. Our findings do not provide strong supportive evidence for the contribution of genetic variants in AMH-related genes to the risk of developing breast cancer in either Caucasians or African Americans.",
keywords = "Anti-Mullerian hormone, Anti-Mullerian hormone receptors, Breast cancer, Single nucleotide polymorphism",
author = "Hongmei Nan and Dorgan, {Joanne F.} and Rebbeck, {Timothy R.}",
year = "2014",
month = "1",
day = "1",
language = "English (US)",
volume = "5",
pages = "145--151",
journal = "International Journal of Molecular Epidemiology and Genetics",
issn = "1948-1756",
publisher = "e-Century Publishing Corporation",
number = "3",

}

TY - JOUR

T1 - Genetic variants in anti-mullerian hormone and anti-mullerian hormone receptor genes and breast cancer risk in caucasians and African Americans

AU - Nan, Hongmei

AU - Dorgan, Joanne F.

AU - Rebbeck, Timothy R.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Anti-Mullerian hormone (AMH) regulates ovarian folliculogenesis by signaling via its receptors, and elevat­ed serum AMH levels are associated with an increased risk of breast cancer. No previous studies have examined the effects of genetic variants in AMH-related genes on breast cancer risk. We evaluated the associations of 62 single nucleotide polymorphisms (SNPs) in AMH and its receptor genes, including AMH type 1 receptor (ACVR1) and AMH type 2 receptor (AMHR2), with the risk of breast cancer in the Women’s Insights and Shared Experiences (WISE) Study of Caucasians (346 cases and 442 controls), as well as African Americans (149 cases and 246 controls). Of the 62 SNPs evaluated, two showed a nominal significant association (P for trend < 0.05) with breast cancer risk among Caucasians, and another two among African Americans. The age-adjusted additive odds ratios (ORs) (95% confidence interval (95% CI)) of those two SNPs (ACVR1 rs12694937[C] and ACVR1 rs2883605[T]) for the risk of breast cancer among Caucasian women were 2.33 (1.20-4.52) and 0.68 (0.47-0.98), respectively. The age-adjusted additive ORs (95% CI) of those two SNPs (ACVR1 rs1146031[G] and AMHR2 functional SNP rs2002555[G]) for the risk of breast cancer among African American women were 0.63 (0.44-0.92) and 1.67 (1.10-2.53), respectively. However, these SNPs did not show significant associations after correction for multiple testing. Our findings do not provide strong supportive evidence for the contribution of genetic variants in AMH-related genes to the risk of developing breast cancer in either Caucasians or African Americans.

AB - Anti-Mullerian hormone (AMH) regulates ovarian folliculogenesis by signaling via its receptors, and elevat­ed serum AMH levels are associated with an increased risk of breast cancer. No previous studies have examined the effects of genetic variants in AMH-related genes on breast cancer risk. We evaluated the associations of 62 single nucleotide polymorphisms (SNPs) in AMH and its receptor genes, including AMH type 1 receptor (ACVR1) and AMH type 2 receptor (AMHR2), with the risk of breast cancer in the Women’s Insights and Shared Experiences (WISE) Study of Caucasians (346 cases and 442 controls), as well as African Americans (149 cases and 246 controls). Of the 62 SNPs evaluated, two showed a nominal significant association (P for trend < 0.05) with breast cancer risk among Caucasians, and another two among African Americans. The age-adjusted additive odds ratios (ORs) (95% confidence interval (95% CI)) of those two SNPs (ACVR1 rs12694937[C] and ACVR1 rs2883605[T]) for the risk of breast cancer among Caucasian women were 2.33 (1.20-4.52) and 0.68 (0.47-0.98), respectively. The age-adjusted additive ORs (95% CI) of those two SNPs (ACVR1 rs1146031[G] and AMHR2 functional SNP rs2002555[G]) for the risk of breast cancer among African American women were 0.63 (0.44-0.92) and 1.67 (1.10-2.53), respectively. However, these SNPs did not show significant associations after correction for multiple testing. Our findings do not provide strong supportive evidence for the contribution of genetic variants in AMH-related genes to the risk of developing breast cancer in either Caucasians or African Americans.

KW - Anti-Mullerian hormone

KW - Anti-Mullerian hormone receptors

KW - Breast cancer

KW - Single nucleotide polymorphism

UR - http://www.scopus.com/inward/record.url?scp=84908216903&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84908216903&partnerID=8YFLogxK

M3 - Article

VL - 5

SP - 145

EP - 151

JO - International Journal of Molecular Epidemiology and Genetics

JF - International Journal of Molecular Epidemiology and Genetics

SN - 1948-1756

IS - 3

ER -